CytoReason Company
CytoReason develops a cell-centered computational model of the human body designed to discover complex patterns in biological data. The company collects proprietary data from pharma companies and uses it to simulate human diseases tissue by tissue, cell by cell. With CytoReason’s massive database and AI-led platform, pharma and biotech companies identify new opportunities, shorten trial phases, reduce development costs and increase the likelihood of approval.
Founded Date:
2016-09-01
Last Funding Date:
2024-07-17
Industry:
Quantum Biology
Total Funding:
100000000
Headquarters:
Tel Aviv,Tel Aviv,Israel,Asia
Employee Number:
101-250
Funding Status:
private
Super Industry:
Quantum Science Applications
Funding Stage:
Early Stage Venture
Funding Total Value:
100000000
Last Funding Total Usd:
80000000
Last Funding Total Currency:
USD
Last Funding Total Value:
80000000
Founders:
David Harel,Elina Starosvetsky,Ksenya Kveler,Renaud Gaujoux,Shai Shen-Orr,Yuval Kalugny